Announcements Trials

Browse Landscape

Phase

Status

Completed 6 Active not recruiting 3 Withdrawn 1 Terminated 1 Recruiting 1

Sponsor Class

OTHER 24 INDUSTRY 12 OTHER_GOV 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Specimen Handling 39 Magnetic Resonance Spectroscopy 30 Carboplatin 14 Biopsy 14 Radiation 13 Cyclophosphamide 13 Radiotherapy 11 daratumumab 10 Vincristine 10 Dexamethasone 10 Surgical Procedures, Operative 9 Etoposide 9 Lenalidomide 8 X-Rays 7 Observation 7 Leucovorin 7 Irinotecan 7 Doxorubicin 7 Cisplatin 7 durvalumab 6 dexamethasone acetate 6 dexamethasone 21-phosphate 6 auricularum 6 Watchful Waiting 6 Radiosurgery 6 Docetaxel 6 Calcium Dobesilate 6 pembrolizumab 5 Stem Cell Transplantation 5 Standard of Care 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × NETWORK × Anastrozole × Clear all

NCT05512364 2026-05-15

TREAT ctDNA

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡